Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti–PD-1 Immunotherapy

Journal:

Cancer Research

Published:

2025-12-01

DOI:

10.1158/0008-5472.can-24-3095

Affiliations:

13

Authors:

29

Go to article

Institutions	Authors	Share
Free University of Brussels (VUB), Belgium	12.500000 12.500000	0.43
VIB-UGent Center for Inflammation Research (IRC), Belgium	9.666667	0.33
Flanders Institute for Biotechnology (VIB), Belgium	3.000000	0.10
University Hospital, VUB, Belgium	1.500000	0.05
JJP Biologics, Poland	1.000000	0.03
Cancer Research Institute Gent (CRIG), Belgium	0.666667	0.02
Ghent University (UGent), Belgium	0.666667	0.02

Interested in Immunology?